Several overseas-born groups have higher rates of liver, stomach, thyroid and pancreatic cancer diagnosis while rates of ...
KFF Health News on MSN
Listen to the latest 'KFF Health News Minute'
The "KFF Health News Minute” brings original health care and health policy reporting from our newsroom to the airwaves each ...
17mon MSN
Doctors provide new hope for pancreatic cancer patients with less invasive radiofrequency ablation
UT Health San Antonio Multispecialty and Research Hospital became the first in South Texas to use an emerging and ...
19hon MSN
Clinical trial of personalized cancer vaccine demonstrates feasibility, safety, immune activation
The first-in-human clinical phase I trial assessing the feasibility and safety of WDVAX, an immunostimulatory ...
Neoantigen vaccines are at the forefront of cancer research, driving personalized immunotherapy and improving outcomes ...
The approval could help Enhertu, which is already a multibillion-dollar seller, supplant a regimen that’s been the standard ...
The FDA approved fam-trastuzumab derextecan-nki (Enhertu; Daiichi Sankyo, Inc), a HER2-directed antibody-drug conjugate (ADC), in combination with pertuzumab as a first-line treatment for patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback